Spectral AI Demonstrates Burn Wound AI System at Southern Regional Burn Conference
Event summary
- Spectral AI showcased its DeepView® System at the Southern Regional Burn Conference (SRBC) from September 10-12, 2026.
- The system was the subject of key opinion leader (KOL) presentations by James Hwang, MD (UAB Burn Center) and Jeffrey Carter, MD (UMCNO).
- DeepView® System received FDA De Novo Classification in May 2026 and UKCA authorization in February 2024.
- The system combines multispectral imaging with AI to assess burn wound healing potential in 20-25 seconds.
- Spectral AI is scheduled to present at the Midwest Region Burn Conference (October 22-23, 2026) and Northeast Region Burn Conference (November 13-14, 2026).
The big picture
Spectral AI's participation at the Southern Regional Burn Conference underscores the growing intersection of AI and medical diagnostics in wound care. The FDA's De Novo Classification of the DeepView® System positions Spectral AI as a key player in the burn wound assessment market. The company's focus on faster, data-driven treatment decisions aligns with broader industry trends toward precision medicine and AI-driven diagnostics.
What we're watching
- Adoption Pace
- The pace at which burn care clinicians adopt the DeepView® System following its FDA approval.
- Regulatory Expansion
- Whether Spectral AI can secure additional regulatory approvals beyond the U.S. and UK.
- Competitive Positioning
- How Spectral AI differentiates itself in the growing market for AI-driven medical diagnostics.